Yachuang Medicine
Latest round
- Series B
Last raised
- Apr 2021
Total raised
- $40M
Investors
- 3
About Yachuang Medicine
Yachuang Medicine, founded in 2016, is headquartered in Shanghai, China. The company focuses on developing treatments for chronic liver diseases., is committed to developing innovative therapies targeting chronic liver diseases like Non-alcoholic Steatohepatitis (NASH) and Chronic Hepatitis B Infection (HBV). Their lead drug candidate, HPG1860, is currently undergoing Phase I clinical trials to meet the needs of patients affected by NASH, which is characterized by liver inflammation and fat accumulation.Yachuang Medicine generates revenue primarily through the advancement and commercialization of its therapeutic candidates, focusing on partnerships with pharmaceutical companies and research institutions. The revenue structure involves licensing agreements, milestone payments upon achieving clinical endpoints, and royalties from future sales of marketed products.00 mn in April 2021, Yachuang Medicine aims to expand its product offerings and geographic reach. The company plans to enhance its presence in North America and Europe, with strategic partnerships to accelerate market entry and product commercialization.
Who invested in Yachuang Medicine
3 investors across 2 rounds
See all investors in Yachuang Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yachuang Medicine
Who invested in Yachuang Medicine?
Yachuang Medicine has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yachuang Medicine raised?
Yachuang Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Yachuang Medicine last raise money?
Yachuang Medicine's most recent round on record is a Series B, in Apr 2021.
What does Yachuang Medicine do?
Yachuang Medicine, founded in 2016, is headquartered in Shanghai, China.
Where is Yachuang Medicine headquartered?
Yachuang Medicine is headquartered in Shanghai, China.
Which VCs invest in companies like Yachuang Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Yachuang Medicine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Yachuang Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.